Summary & Overview
HCPCS Q4421: Biolab Membrane Wrap Solo, Per Square Centimeter
HCPCS Level II code Q4421 identifies a biolab membrane wrap, billed per square centimeter as an add-on item in addition to a primary surgical procedure. As a product-focused add-on code, Q4421 is used to capture the use of a biologic membrane implanted or applied intraoperatively to support tissue coverage, grafting, or repair. Nationally, such codes matter for tracking the use of costly biologic adjuncts, ensuring appropriate reimbursement layering on top of base procedure payments, and enabling supply utilization monitoring.
Key payers included in the coverage landscape are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical role and service context, payer coverage considerations, and where this add-on code fits within surgical billing workflows. The publication presents benchmarks and policy-relevant points for payers and billing teams, explains site-of-service implications (hospital OR and ambulatory surgery centers), and summarizes typical documentation elements associated with add-on biologic products. Data not available in the input for specific modifiers, associated taxonomies, ICD-10 pairings, and related codes.
Billing Code Overview
HCPCS Level II code Q4421 describes a biolab membrane wrap solo, billed per square centimeter as an add-on item to be listed separately in addition to a primary procedure. This code represents a biologic membrane product used to cover, protect, or support tissue during surgical procedures.
-
Service type: Surgical implant/biologic adjunct used during operative procedures
-
Typical site of service: Hospital operating room, ambulatory surgery center, or other procedural/surgical settings
Clinical & Coding Specifications
Clinical Context
A patient with a chronic non-healing full-thickness or complex partial-thickness wound (for example, a diabetic foot ulcer or a postoperative dehisced incision) presents to a wound care clinic or outpatient surgical center for biologic membrane augmentation. The care team — typically a wound care physician or surgeon, a specialized nurse or advanced practice provider, and a wound care coordinator — evaluates the wound, performs wound bed preparation (sharp debridement, infection control, moisture balance), and determines that placement of a biologic membrane product is indicated to provide a protective scaffold and promote epithelialization.
During the visit, the clinician measures the wound area in square centimeters and orders a Q4421 product (Biolab membrane wrap solo, billed per square centimeter as an add-on). The membrane is trimmed to size, placed over the prepared wound, and secured per manufacturer instructions. Typical documentation includes wound measurements, debridement details, product lot number, number of square centimeters applied, and whether an add-on code is billed in conjunction with a primary procedure code (such as debridement or an excisional procedure). The typical site of service is an outpatient wound care clinic, ambulatory surgical center, or physician office. Post-application care includes dressing changes, infection surveillance, and scheduled clinic follow-up visits for reassessment and potential repeat application.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 |